Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 9 studies | 31% ± 11% | |
| endothelial cell | 8 studies | 24% ± 7% | |
| glutamatergic neuron | 8 studies | 35% ± 20% | |
| type I pneumocyte | 7 studies | 26% ± 5% | |
| GABAergic neuron | 7 studies | 34% ± 19% | |
| astrocyte | 7 studies | 25% ± 9% | |
| oligodendrocyte | 6 studies | 23% ± 4% | |
| epithelial cell | 5 studies | 33% ± 13% | |
| neuron | 4 studies | 30% ± 7% | |
| type II pneumocyte | 4 studies | 19% ± 5% | |
| goblet cell | 4 studies | 26% ± 13% | |
| interneuron | 4 studies | 37% ± 21% | |
| microglial cell | 3 studies | 22% ± 2% | |
| fibroblast | 3 studies | 19% ± 3% | |
| macrophage | 3 studies | 19% ± 2% | |
| transit amplifying cell | 3 studies | 28% ± 16% | |
| granule cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7912.96 | 1445 / 1445 | 100% | 83.33 | 183 / 183 |
| pancreas | 100% | 5371.68 | 328 / 328 | 100% | 89.94 | 178 / 178 |
| thymus | 100% | 9894.31 | 653 / 653 | 100% | 126.14 | 605 / 605 |
| brain | 100% | 8367.02 | 2640 / 2642 | 100% | 182.33 | 705 / 705 |
| prostate | 100% | 8262.44 | 245 / 245 | 100% | 127.04 | 501 / 502 |
| stomach | 100% | 5471.03 | 359 / 359 | 100% | 77.19 | 285 / 286 |
| breast | 100% | 6529.34 | 459 / 459 | 100% | 92.53 | 1114 / 1118 |
| skin | 100% | 11043.07 | 1809 / 1809 | 100% | 87.23 | 470 / 472 |
| kidney | 100% | 6255.98 | 89 / 89 | 100% | 85.69 | 897 / 901 |
| uterus | 100% | 7676.45 | 170 / 170 | 99% | 93.20 | 456 / 459 |
| lung | 100% | 6921.85 | 577 / 578 | 99% | 98.88 | 1149 / 1155 |
| bladder | 100% | 7214.29 | 21 / 21 | 99% | 90.14 | 500 / 504 |
| intestine | 100% | 7210.26 | 966 / 966 | 99% | 82.33 | 522 / 527 |
| ovary | 100% | 7963.77 | 180 / 180 | 98% | 65.05 | 423 / 430 |
| liver | 100% | 3540.40 | 225 / 226 | 98% | 58.43 | 396 / 406 |
| adrenal gland | 100% | 6199.53 | 258 / 258 | 96% | 72.70 | 220 / 230 |
| adipose | 100% | 5429.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 74.74 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 44.21 | 29 / 29 |
| spleen | 100% | 5784.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 92.40 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 84.86 | 1 / 1 |
| blood vessel | 100% | 7404.75 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 3582.32 | 796 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 4207.45 | 847 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 5657.19 | 857 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050890 | Biological process | cognition |
| GO_0007155 | Biological process | cell adhesion |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0016020 | Cellular component | membrane |
| GO_0030246 | Molecular function | carbohydrate binding |
| Gene name | DGCR2 |
| Protein name | DiGeorge syndrome critical region gene 2, isoform CRA_c (cDNA FLJ50536, highly similar to Integral membrane protein DGCR2/IDD) Integral membrane protein DGCR2/IDD DiGeorge syndrome critical region gene 2 |
| Synonyms | DKFZp686I1730 KIAA0163 hCG_17243 IDD |
| Description | FUNCTION: Putative adhesion receptor, that could be involved in cell-cell or cell-matrix interactions required for normal cell differentiation and migration. |
| Accessions | ENST00000537045.5 [P98153-2] F6SYP7 ENST00000263196.12 [P98153-1] ENST00000389262.8 B7Z3C4 Q8IWC8 ENST00000545799.5 P98153 Q5CZ70 |